Grant: Catalyst Grant: Secondary Analysis of Neuroimaging Databases
McGill University
$100,000.00
Anatomical and functional correlates of metabolic change and cognitive decline in Alzheimer's disease: Multivariate approaches for early identification of at-risk population
FY 2013-14
Summary
Alzheimer's disease (AD) is one of the most common forms of dementia related to ageing. AD currently affects more than 450,000 Canadians, and this number is expected to double in the next two decades (Alzheimer's Foundation for Caregiving in Canada; Statistics Canada). Early recognition of the symptoms that may develop into AD, such as memory loss and mild cognitive impairment, provide an opportunity to slow their progression with the application of emerging therapeutic interventions. These novel medical treatments have been shown to work best when administered at the earliest stages of the disease. Thus, development of more effective therapeutics targeting these early signs should benefit from early identification of the precursor stages of AD.
The pathogenesis of AD affects brain tissue microstructure. These events in turn affect cerebral activity (electrophysiology) and energy metabolism (chemistry). Neuroimaging studies have shown the existence of characteristic anatomical and functional connectivity patterns in subjects with AD or mild cognitive impairment. Measuring the brain's structural and functional integrity may allow us to predict symptom progression, identify subjects at risk for AD, and offer earlier therapeutic intervention.
Department
Program
Catalyst Grant: Secondary Analysis of Neuroimaging Databases
Recipient
Location
Quebec, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database
As published
Id
293605
Name
Evans Alan C
Region
Québec
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Biomedical
Prcname2
Catalyst Grant: Secondary Analysis of Neuroimaging Databases
Projecttitle
Anatomical and functional correlates of metabolic change and cognitive decline in Alzheimer's disease: Multivariate approaches for early identification of at-risk population
Programtype2
Operating Grants
Orgnameinp2
McGill University
Cihramount2
$100,000
Cihrequipment2
$0
Programname2
Catalyst Grant: Secondary Analysis of Neuroimaging Databases
Keyworddelim
Alzheimer'S Disease; Dti; Functional Connectivity; Mri; Multivariate Analysis; Pet; Structural Connectivity
Abstract
Alzheimer's disease (AD) is one of the most common forms of dementia related to ageing. AD currently affects more than 450,000 Canadians, and this number is expected to double in the next two decades (Alzheimer's Foundation for Caregiving in Canada; Statistics Canada). Early recognition of the symptoms that may develop into AD, such as memory loss and mild cognitive impairment, provide an opportunity to slow their progression with the application of emerging therapeutic interventions. These novel medical treatments have been shown to work best when administered at the earliest stages of the disease. Thus, development of more effective therapeutics targeting these early signs should benefit from early identification of the precursor stages of AD.
The pathogenesis of AD affects brain tissue microstructure. These events in turn affect cerebral activity (electrophysiology) and energy metabolism (chemistry). Neuroimaging studies have shown the existence of characteristic anatomical and functional connectivity patterns in subjects with AD or mild cognitive impairment. Measuring the brain's structural and functional integrity may allow us to predict symptom progression, identify subjects at risk for AD, and offer earlier therapeutic intervention.
Competitiondate
201310
Approvedterm2
2 yrs 0 mth
Pinamesdelim
Evans, Alan C
Approvedterm
2 ans 0 mois
Cihrcontribution2
~ $100,000~ $0~